Clinical Trials Browser

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

996 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06474182 2025-09-25

ProApix

Phase NA Recruiting

32 enrolled

Plasma cell

Multiple Myeloma

NCT07160686 2025-09-08

THROMBO-STOP

Phase 3 Not yet recruiting

1,456 enrolled

Thromboprophylaxis

NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Phase 4 Recruiting

100 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

330 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

30 enrolled

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Clinical Trials

ASTER

DOAC

ProApix

THROMBO-STOP

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

MYELAXAT

CARAVAGGIO

STREAM-Line

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Apixaban in Thrombocytopenia